ERWINASE recall in Canada: Particulate matter
In plain language
This recall involves ERWINASE (Erwinia L-asparaginase) injection sold in Canada. It's being recalled because some vials may contain particulate matter. Healthcare professionals should follow specific instructions for use and administration.
What to do
- Stop using the product if particulate matter is observed on or in the product.
- Use a standard 5-micron filter needle when preparing the product.
- Refer to the ERWINASE Canadian Product Monograph for prescribing information.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
ERWINASE (Erwinia L-asparaginase)
Lot: CAMR-183a, sub-lot CAMR-183aG117, CAMR-184a, sub-lot CAMR-184aG117, CAMR-185a, sub-lot CAMR-185aG117
Why this matters
Particulate matter in injection
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: CAMR-183a, sub-lot CAMR-183aG117, CAMR-184a, sub-lot CAMR-184aG117, CAMR-185a, sub-lot CAMR-185aG117
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Particulate matter in injection
What should consumers do?
Stop using the product if particulate matter is observed on or in the product. Use a standard 5-micron filter needle when preparing the product. Refer to the ERWINASE Canadian Product Monograph for prescribing information.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Particulate matter in injection
When was this product recalled?
This product was recalled on February 27, 2018.
Is the ERWINASE brand affected by this recall?
Yes, ERWINASE products are affected by this recall. This recall involves ERWINASE (Erwinia L-asparaginase) injection sold in Canada. It's being recalled because some vials may contain particulate matter. Healthcare professionals should follow specific instructions for use and administration.